Similar Items: Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies
- Correction to ‘Casδ, an evolutionary transitional CRISPR system enables efficient genome editing across animals and plants’
- Organoid technology in cancer research
- Correction to: Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction
- Organoids as translational models in neuroregeneration after central nervous system injury
- Correction: Generation of a transparent killifish line through multiplex CRISPR/Cas9mediated gene inactivation
- Bridging Kidney Organoid Innovation and Regenerative Medicine: Current Advances and Future Directions